Whitton AE, Treadway MT, Pizzagalli DA. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry. 2015;28:7–12. https://doi.org/10.1097/YCO.0000000000000122.
Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19:470–84. https://doi.org/10.1038/s41583-018-0029-9.
Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. AJP. 2001;158:1783–93. https://doi.org/10.1176/appi.ajp.158.11.1783.
Kulacaoglu F, Kose S. Singing under the impulsiveness: impulsivity in psychiatric disorders. Psychiatry Clin Psychopharmacol. 2018;28:205–10. https://doi.org/10.1080/24750573.2017.1410329.
Dalley JW, Roiser JP. Dopamine, serotonin and impulsivity. Neuroscience. 2012;215:42–58. https://doi.org/10.1016/j.neuroscience.2012.03.065.
Grotzinger AD, Werme J, Peyrot WJ, Frei O, de Leeuw C, Bicks LK, et al. Mapping the genetic landscape across 14 psychiatric disorders. Nature. 2026;649:406–15. https://doi.org/10.1038/s41586-025-09820-3.
Uher R. Gene-environment interactions in severe mental illness. Front Psychiatry. 2014;5:48 https://doi.org/10.3389/fpsyt.2014.00048.
Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci. 2007;8:755–65. https://doi.org/10.1038/nrn2212.
Goodman AB. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA. 1998;95:7240–4. https://doi.org/10.1073/pnas.95.13.7240.
Castro DS, Hermanson E, Joseph B, Wallén A, Aarnisalo P, Heller A, et al. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J Biol Chem. 2001;276:43277–84. https://doi.org/10.1074/jbc.M107013200.
Korecka JA, van Kesteren RE, Blaas E, Spitzer SO, Kamstra JH, Smit AB, et al. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013;8:e63862. https://doi.org/10.1371/journal.pone.0063862.
Rataj-Baniowska M, Niewiadomska-Cimicka A, Paschaki M, Szyszka-Niagolov M, Carramolino L, Torres M, et al. Retinoic acid receptor β controls development of striatonigral projection neurons through FGF-dependent and Meis1-dependent mechanisms. J Neurosci. 2015;35:14467–75. https://doi.org/10.1523/JNEUROSCI.1278-15.2015.
Podleśny-Drabiniok A, Sobska J, De Lera AR, Gołembiowska K, Kamińska K, Dollé P, et al. Distinct retinoic acid receptor (RAR) isotypes control differentiation of embryonal carcinoma cells to dopaminergic or striatopallidal medium spiny neurons. Sci Rep. 2017;7:13671. https://doi.org/10.1038/s41598-017-13826-x.
Chatzi C, Brade T, Duester G. Retinoic acid functions as a key GABAergic differentiation signal in the basal Ganglia. Palmer TD, editor. PLoS Biol. 2011;9:e1000609. https://doi.org/10.1371/journal.pbio.1000609
Lane MA, Bailey SJ. Role of retinoid signalling in the adult brain. Prog Neurobiol. 2005;75:275–93. https://doi.org/10.1016/j.pneurobio.2005.03.002.
Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66:606–30. https://doi.org/10.1002/neu.20242.
Kreżel W, Kastner P, Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience. 1999;89:1291–300. https://doi.org/10.1016/S0306-4522(98)00342-X.
Zetterström RH, Lindqvist E, De Urquiza AM, Tomac A, Eriksson U, Perlmann T, et al. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci. 1999;11:407–16. https://doi.org/10.1046/j.1460-9568.1999.00444.x.
Krȩżel W, Ghyselinck N, Samad TA, Dupé V, Kastner P, Borrelli E, et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science. 1998;279:863–7.
Molotkova N, Molotkov A, Duester G. Role of retinoic acid during forebrain development begins late when Raldh3 generates retinoic acid in the ventral subventricular zone. Dev Biol. 2007;303:601–10. https://doi.org/10.1016/j.ydbio.2006.11.035.
Krzyżosiak A, Szyszka-Niagolov M, Wietrzych M, Gobaille S, Muramatsu Sichi, Krężel W. Retinoid X receptor gamma control of affective behaviors involves Dopaminergic signaling in mice. Neuron. 2010;66:908–20. https://doi.org/10.1016/j.neuron.2010.05.004.
Niewiadomska-Cimicka A, Krzyżosiak A, Ye T, Podleśny-Drabiniok A, Dembélé D, Dollé P, et al. Genome-wide analysis of RARβ transcriptional targets in mouse striatum links retinoic acid signaling with Huntington’s disease and other neurodegenerative disorders. Mol Neurobiol. 2017;54:3859–78. https://doi.org/10.1007/s12035-016-0010-4.
Zhang Y, Crofton EJ, Smith TES, Koshy S, Li D, Green TA. Manipulation of retinoic acid signaling in the nucleus accumbens shell alters rat emotional behavior. Behav Brain Res. 2019;376:112177. https://doi.org/10.1016/j.bbr.2019.112177.
Godino A, Salery M, Durand-de Cuttoli R, Estill MS, Holt LM, Futamura R, et al. Transcriptional control of nucleus accumbens neuronal excitability by retinoid X receptor alpha tunes sensitivity to drug rewards. Neuron. 2023;S0896627323001174. https://doi.org/10.1016/j.neuron.2023.02.013.
Marie A, Leroy J, Darricau M, Alfos S, De Smedt-Peyrusse V, Richard E, et al. Preventive vitamin A supplementation improves striatal function in 6-hydroxydopamine hemiparkinsonian rats. Front Nutr. 2022;9:811843. https://doi.org/10.3389/fnut.2022.811843.
Borel P, Troadec R, Damiani M, Halimi C, Nowicki M, Guichard P, et al. β-carotene bioavailability and conversion efficiency are significantly affected by sex in rats: first observation suggesting a possible hormetic regulation of vitamin a metabolism in female rats. Mol Nutr Food Res. 2021;65:2100650. https://doi.org/10.1002/mnfr.202100650.
Marie A, Kinet R, Helbling J, Darricau M, Alfos S, Di Miceli M, et al. Impact of dietary vitamin A on striatal function in adult rats. FASEB J. 2023;37:e23037. https://doi.org/10.1096/fj.202300133R.
Trifilieff P, Martinez D. Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology. 2014;76:498–509. https://doi.org/10.1016/j.neuropharm.2013.06.031.
Steel P. The nature of procrastination: a meta-analytic and theoretical review of quintessential self-regulatory failure. Psychol Bull. 2007;133:65–94. https://doi.org/10.1037/0033-2909.133.1.65.
Steel P, König CJ. Integrating theories of motivation. AMR. 2006;31:889–913. https://doi.org/10.5465/amr.2006.22527462.
Wypych M, Matuszewski J, Dragan WL. Roles of impulsivity, motivation, and emotion regulation in procrastination – path analysis and comparison between students and non-students. Front Psychol. 2018;9:891. https://doi.org/10.3389/fpsyg.2018.00891.
Petitet P, Scholl J, Attaallah B, Drew D, Manohar S, Husain M. The relationship between apathy and impulsivity in large population samples. Sci Rep. 2021;11:4830. https://doi.org/10.1038/s41598-021-84364-w.
Salamone JD, Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron. 2012;76:470–85. https://doi.org/10.1016/j.neuron.2012.10.021.
Berke JD. What does dopamine mean? Nat Neurosci. 2018;21:787–93. https://doi.org/10.1038/s41593-018-0152-y.
Cagniard B, Balsam PD, Brunner D, Zhuang X. Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacol. 2006;31:1362–70. https://doi.org/10.1038/sj.npp.1300966.
Balci F, Ludvig EA, Abner R, Zhuang X, Poon P, Brunner D. Motivational effects on interval timing in dopamine transporter (DAT) knockdown mice. Brain Res. 2010;1325:89–99. https://doi.org/10.1016/j.brainres.2010.02.034.
Milienne-Petiot M, Kesby JP, Graves M, Van Enkhuizen J, Semenova S, Minassian A, et al. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania. Neuropharmacology. 2017;113:260–70. https://doi.org/10.1016/j.neuropharm.2016.07.030.
Carpenter AC, Saborido TP, Stanwood GD. Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice. Dev Neurosci. 2012;34:250–7. https://doi.org/10.1159/000336824.
Davis GL, Stewart A, Stanwood GD, Gowrishankar R, Hahn MK, Blakely RD. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res. 2018;337:61–9. https://doi.org/10.1016/j.bbr.2017.09.043.
Yamashita M, Sakakibara Y, Hall FS, Numachi Y, Yoshida S, Kobayashi H, et al. Impaired cliff avoidance reaction in dopamine transporter knockout mice. Psychopharmacology. 2013;227:741–9. https://doi.org/10.1007/s00213-013-3009-9.
Cinque S, Zoratto F, Poleggi A, Leo D, Cerniglia L, Cimino S, et al. Behavioral phenotyping of dopamine transporter knockout rats: compulsive traits, motor stereotypies, and anhedonia. Front Psychiatry. 2018;9:43. https://doi.org/10.3389/fpsyt.2018.00043.
Salahpour A, Medvedev IO, Beaulieu JM, Gainetdinov RR, Caron MG. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry. 2007;61:65–9. https://doi.org/10.1016/j.biopsych.2006.03.020.
Cagniard B, Sotnikova TD, Gainetdinov RR, Zhuang X. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. J Neurogenet. 2014;28:112–21. https://doi.org/10.3109/01677063.2014.908191.
Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci. 1998;18:1979–86. https://doi.org/10.1523/JNEUROSCI.18-06-01979.1998.
Spielewoy C, Biala G, Roubert C, Hamon M, Betancur C, Giros B. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berl). 2001;159:2–9. https://doi.org/10.1007/s002130100901.
Salamone JD, Correa M, Yang JH, Rotolo R, Presby R. Dopamine, effort-based choice, and behavioral economics: basic and translational research. Front Behav Neurosci. 2018;12:52. https://doi.org/10.3389/fnbeh.2018.00052.
Sotnikova TD, Efimova EV, Gainetdinov RR. Enhanced dopamine transmission and hyperactivity in the dopamine transporter heterozygous mice lacking the D3 dopamine receptor. IJMS. 2020;21:8216. https://doi.org/10.3390/ijms21218216.
Le Foll B, Diaz J, Sokoloff P. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 2005;76:1281–96. https://doi.org/10.1016/j.lfs.2004.09.018.
Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA. 2001;98:1982–7.
Eshel N, Touponse GC, Wang AR, Osterman AK, Shank AN, Groome AM, et al. Striatal dopamine integrates cost, benefit, and motivation. Neuron. 2024;112:500.e5. https://doi.org/10.1016/j.neuron.2023.10.038.
Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 2003;299:1898–902. https://doi.org/10.1126/science.1077349.
Maes EJP, Sharpe MJ, Usypchuk AA, Lozzi M, Chang CY, Gardner MPH, et al. Causal evidence supporting the proposal that dopamine transients function as temporal difference prediction errors. Nat Neurosci. 2020;23:176–8. https://doi.org/10.1038/s41593-019-0574-1.
Ko D, Wanat MJ. Phasic dopamine transmission reflects initiation vigor and exerted effort in an action- and region-specific manner. J Neurosci. 2016;36:2202–11. https://doi.org/10.1523/JNEUROSCI.1279-15.2016.
Bailey MR, Simpson EH, Balsam PD. Neural substrates underlying effort, time, and risk-based decision making in motivated behavior. Neurobiol Learn Mem. 2016;133:233–56. https://doi.org/10.1016/j.nlm.2016.07.015.
Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007;30:194–202. https://doi.org/10.1016/j.tins.2007.03.006.
Salinas AG, Lee JO, Augustin SM, Zhang S, Patriarchi T, Tian L, et al. Distinct sub-second dopamine signaling in dorsolateral striatum measured by a genetically-encoded fluorescent sensor. Nat Commun. 2023;14:5915. https://doi.org/10.1038/s41467-023-41581-3.
Beeler JA, Mourra D, Zanca RM, Kalmbach A, Gellman C, Klein BY, et al. Vulnerable and resilient phenotypes in a mouse model of anorexia nervosa. Biol Psychiatry. 2021;90:829–42. https://doi.org/10.1016/j.biopsych.2020.06.030.
Suri D, Zanni G, Mahadevia D, Chuhma N, Saha R, Spivack S, et al. Dopamine transporter blockade during adolescence increases adult dopamine function, impulsivity, and aggression. Mol Psychiatry. 2023;28:3512–23. https://doi.org/10.1038/s41380-023-02194-w.
Golden CEM, Martin AC, Kaur D, Mah A, Levy DH, Yamaguchi T, et al. Estrogen modulates reward prediction errors and reinforcement learning. Nat Neurosci. 2025;28:2502–14. https://doi.org/10.1038/s41593-025-02104-z.
Samad TA, Krezel W, Chambon P, Borrelli E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor–retinoid X receptor family. Proc Natl Acad Sci USA. 1997;94:14349–54. https://doi.org/10.1073/pnas.94.26.14349.
Liao WL, Tsai HC, Wang HF, Chang J, Lu KM, Wu HL, et al. Modular patterning of structure and function of the striatum by retinoid receptor signaling. Proc Natl Acad Sci USA. 2008;105:6765–70. https://doi.org/10.1073/pnas.0802109105.
Song R, Zhang HY, Li X, Bi GH, Gardner EL, Xi ZX. Increased vulnerability to cocaine in mice lacking dopamine D 3 receptors. Proc Natl Acad Sci USA. 2012;109:17675–80. https://doi.org/10.1073/pnas.1205297109.
Simpson EH, Winiger V, Biezonski DK, Haq I, Kandel ER, Kellendonk C. Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition. Biol Psychiatry. 2014;76:823–31. https://doi.org/10.1016/j.biopsych.2013.11.023.
Trifilieff P, Feng B, Urizar E, Winiger V, Ward RD, Taylor KM, et al. Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol Psychiatry. 2013;18:1025–33. https://doi.org/10.1038/mp.2013.57.
Gallo EF, Meszaros J, Sherman JD, Chohan MO, Teboul E, Choi CS, et al. Accumbens dopamine D2 receptors increase motivation by decreasing inhibitory transmission to the ventral pallidum. Nat Commun. 2018;9:1086. https://doi.org/10.1038/s41467-018-03272-2.
Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, et al. Dopaminergic network differences in human impulsivity. Science. 2010;329:532. https://doi.org/10.1126/science.1185778.
Moreno M, Economidou D, Mar AC, López-Granero C, Caprioli D, Theobald DE, et al. Divergent effects of D₂/₃ receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats. Psychopharmacology (Berl). 2013;228:19–30. https://doi.org/10.1007/s00213-013-3010-3.
Besson M, Belin D, McNamara R, Theobald DE, Castel A, Beckett VL, et al. Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology. 2010;35:560–9. https://doi.org/10.1038/npp.2009.162.
Trifilieff P, Ducrocq F, van der Veldt S, Martinez D. Blunted dopamine transmission in addiction: potential mechanisms and implications for behavior. Semin Nucl Med. 2017;47:64–74. https://doi.org/10.1053/j.semnuclmed.2016.09.003.
Enriquez-Traba J, Arenivar M, Yarur-Castillo HE, Noh C, Flores RJ, Weil T, et al. Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors. Nat Neurosci. 2025;28:105–21. https://doi.org/10.1038/s41593-024-01819-9.
Sánchez-Hernández D, Poon AN, Kubant R, Kim H, Huot PSP, Cho CE, et al. High vitamin A intake during pregnancy modifies dopaminergic reward system and decreases preference for sucrose in Wistar rat offspring. J Nutr Biochem. 2016;27:104–11. https://doi.org/10.1016/j.jnutbio.2015.08.020.
Veenvliet JV, Smidt MP. Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. Cell Mol Life Sci. 2014;71:4703–27. https://doi.org/10.1007/s00018-014-1681-5.
Meng SZ, Ozawa Y, Itoh M, Takashima S. Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia. Brain Res. 1999;843:136–44. https://doi.org/10.1016/s0006-8993(99)01933-2.
Green AL, Eid A, Zhan L, Zarbl H, Guo GL, Richardson JR. Epigenetic regulation of the ontogenic expression of the dopamine transporter. Front Genet. 2019;10. https://doi.org/10.3389/fgene.2019.01099.
Rao A, Richards TL, Simmons D, Zahniser NR, Sorkin A. Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons. FASEB J. 2012;26:1921–33. https://doi.org/10.1096/fj.11-196113.
Volkow ND. Drug abuse and mental illness: progress in understanding comorbidity. Am J Psychiatry. 2001;158:1181–3. https://doi.org/10.1176/appi.ajp.158.8.1181.
Perez MF, Ford KA, Goussakov I, Stutzmann GE, Hu XT. Repeated cocaine exposure decreases dopamine D2-like receptor modulation of Ca2+ homeostasis in rat nucleus accumbens neurons. Synapse. 2011;65:168–80. https://doi.org/10.1002/syn.20831.
